BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma

Staying flexible in biomanufacturing with optionality

The biopharma industry offers big rewards – but it poses big risks, too. Rather than fearing the unknown, the concept of optionality can help you bet...

July 15, 2021 | Opinion | By Firman Ghouze, Cytiva, and Uriel Kusiatin, Provista Diagnostics Inc.

Inotiv Acquires Genetic Toxicology Assets from Merck's BioReliance® portfolio

Robert Leasure, Jr., President and CEO of Inotiv, commented, “This transaction with MilliporeSigma adds genetic toxicology to our suite of internal c...

July 14, 2021 | News

Enzymatica and STADA extend agreement on ViruProtect to Vietnam

Enzymatica has licensed to STADA exclusive rights to market and sell ViruProtect® (distributed by Enzymatica as ColdZyme®) in Vietnam. ...

July 14, 2021 | News

USP acquires Pharmatech Associates

United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. ...

July 13, 2021 | News

Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...

July 13, 2021 | News

Everest Medicines Announces Strategic Commercial Partnership with ,Tencent

Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that ad...

July 12, 2021 | News

I-Mab Expands Next Generation Novel Oncology Therapeutics

I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...

July 10, 2021 | News

BD Launches Reimagined Digital Marketplace for Flow Cytometry

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of a new bdbi...

July 08, 2021 | News

Biological E to purchase CpG 1018 adjuvant from Dynavax

DYNAVAX AND BIOLOGICAL E ANNOUNCE COMMERCIAL SUPPLY AGREEMENT OF DYNAVAX’S CpG 1018 ADJUVANT FOR BIOLOGICAL E’S COVID-19 VACCINE CANDIDATE Dyn...

July 06, 2021 | News

SINOMED announces a clinical collaboration with the National University of Ireland Galway

The PIONEER IV trial is a prospective, random trial that will take place in 30 hospitals across Europe, enrolling 2,540 patients and involve patient...

July 05, 2021 | News

Pall Corporation Secures Multi-Million Dollar Contract With Exothera

Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract...

July 01, 2021 | News

Clover Announces Advance Purchase Agreement with Gavi

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...

June 30, 2021 | News

Sanofi to Focus on innovating mRNA vaccines beyond pandemic

Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate t...

June 30, 2021 | News

Evonik markets new advanced technology for sustainable pharmaceutical production

Evonik now offers ‘Chemistry in Water’, to enable classical organic reactions to be performed in water New technology allows drug manufactur...

June 30, 2021 | News

Stay Connected